Abstract
It is the winter of 1990 and a 68-year-old woman with a history of hypertension presents with a syndrome of stuttering chest pain and associated dyspnea. She was working at the time and was encouraged by her coworkers to go to the emergency room. Ultimately, she was admitted to her local hospital and treated for a non-ST elevation myocardial infarction and discharged home. She was told—and believed—that the care she received was excellent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anon. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists’ Collaboration. Br Med J (Clin Res Ed). 1988;296:320–31.
Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509–14.
Tooley SA. The life of Florence Nightingale. London: S.H. Bousfield & Co., Ltd.; 1905. ISBN-13: 978-1104449629.
Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ. 2001;322:1297–300.
Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768–77.
Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3:225–30.
Gillman MW. Primordial prevention of cardiovascular disease. Circulation. 2015;131:599–601.
Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98.
Anon. To err is human. Washington, D.C.: National Academies Press; 2000.
Anon. Crossing the quality chasm. Washington, D.C.: National Academies Press; 2001.
Berwick DM. A user’s manual for the IOM’s ‘quality chasm’ report. Health Aff. 2002;21:80–90.
Blendon RJ, Altman DE, Benson JM, Brodie M. Health care in the 2004 presidential election. N Engl J Med. 2004;351:1314–22.
Anon. No title. Available at: http://www.ahrq.gov/talkingquality/measures/types.html.
Chatterjee P, Joynt KE. Do cardiology quality measures actually improve patient outcomes? J Am Heart Assoc. 2014;3:e000404.
Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015;131:1518–27.
Hannan EL, Kilburn H, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271:761–6.
Omoigui NA, Miller DP, Brown KJ, et al. Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation. 1996;93:27–33.
Peberdy MA, Donnino MW, Callaway CW, et al. Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. Circulation. 2013;128:762–73.
Rowe R, Iqbal J, Murali-krishnan R, et al. Role of frailty assessment in patients undergoing cardiac interventions. Open Heart. 2014;1:e000033–e000033.
Green J, Wintfeld N. Report cards on cardiac surgeons. Assessing New York State’s approach. N Engl J Med. 1995;332:1229–32.
Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209–12.
Forman DE, Maurer MS, Boyd C, et al. Multimorbidity in older adults with cardiovascular disease. J Am Coll Cardiol. 2018;71:2149–61.
Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103–14.
Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation. 1990;82:II117–34.
Gunnar RM, Bourdillon PD, Dixon DW, et al. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommit). Circulation. 1990;82:664–707.
Rosamond WD, Shahar E, McGovern PG, Sides TL, Luepker RV. Trends in coronary thrombolytic therapy for acute myocardial infarction (the Minnesota Heart Survey Registry, 1990 to 1993). Am J Cardiol. 1996;78:271–7.
Gunter N, Moore L, Odom P. Cooperative cardiovascular project. J S C Med Assoc. 1997;93:177–9.
Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351–7.
Masoudi FA, Ralston DL, Wolfe P, et al. Baseline quality indicator rates from the National Heart Failure Project: a HCFA initiative to improve the care of medicare beneficiaries with heart failure. Congest Heart Fail. 7:53–6.
McNaughton H, McPherson K, Taylor W, Weatherall M. Relationship between process and outcome in stroke care. Stroke. 2003;34:713–7.
Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912–20.
Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006;296:72–8.
Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70.
Heidenreich PA, Hernandez AF, Yancy CW, Liang L, Peterson ED, Fonarow GC. Get with the guidelines program participation, process of care, and outcome for medicare patients hospitalized with heart failure. Circ Cardiovasc Qual Outcomes. 2012;5:37–43.
Anon. No title. Available at: http://www.qualityforum.org/Measures_List.aspx.
National Quality Forum. NQF‐Endorsed® Standards. 1999. Available at: http://www.qualityforum.org/Measures_List.aspx.
Berthiaume JT, Chung RS, Ryskina KL, Walsh J, Legorreta AP. Aligning financial incentives with quality of care in the hospital setting. J Healthc Qual. 2006;28:36–44, 51.
Nahra TA, Reiter KL, Hirth RA, Shermer JE, Wheeler JRC. Cost-effectiveness of hospital pay-for-performance incentives. Med Care Res Rev. 2006;63:49S–72S.
Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–96.
Glickman SW, Ou F-S, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA. 2007;297:2373–80.
Centers for Medicare & Medicaid Services (CMS) H. Medicare program; hospital inpatient value-based purchasing program. Final rule. Fed Regist. 2011;76:26490–547.
Ryan AM, Blustein J, Casalino LP. Medicare’s flagship test of pay-for-performance did not spur more rapid quality improvement among low-performing hospitals. Health Aff. 2012;31:797–805.
Hayward RA. Kent DM. 6 EZ steps to improving your performance: (or how to make P4P pay 4U!). JAMA. 2008;300:255–6.
Figueroa JF, Tsugawa Y, Zheng J, Orav EJ, Jha AK. Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ. 2016;353:i2214.
Papanicolas I, Figueroa JF, Orav EJ, Jha AK. Patient hospital experience improved modestly, but no evidence medicare incentives promoted meaningful gains. Health Aff (Millwood). 2017;36:133–40.
Jha AK. Time to get serious about pay for performance. JAMA. 2013;309:347.
Keenan PS, Normand ST, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1:29–37.
Zuckerman RB, Sheingold SH, Orav EJ, Ruhter J, Epstein AM. Readmissions, observation, and the hospital readmissions reduction program. N Engl J Med. 2016;374:1543–51.
Konstam MA. Heart failure in the lifetime of Musca Domestica (the common housefly). JACC Heart Fail. 2013;1:178–80.
Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW. Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA – J Am Med Assoc. 2018;320:2542–52.
Gupta A, Allen LA, Bhatt DL, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3:44.
Krumholz HM, Chaudhry SI, Spertus JA, Mattera JA, Hodshon B, Herrin J. Do non-clinical factors improve prediction of readmission risk? JACC Heart Fail. 2016;4:12–20.
Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the hospital readmissions reduction program. JAMA. 2013;309:342.
Figueroa JF, Joynt KE, Zhou X, Orav EJ, Jha AK. Safety-net hospitals face more barriers yet use fewer strategies to reduce readmissions. Med Care. 2017;55:229–35.
Rathi VK, McWilliams JM. First-year report cards from the Merit-Based Incentive Payment System (MIPS). JAMA. 2019;321:1157.
MacLean CH, Kerr EA, Qaseem A. Time out — charting a path for improving performance measurement. N Engl J Med. 2018;378:1757–61.
O’Brien SM, Shahian DM, Filardo G, et al. The society of thoracic surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42.
Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167–76.
Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–35.
Steyerberg EW, Borsboom GJJM, van Houwelingen HC, Eijkemans MJC, Habbema JDF. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med. 2004;23:2567–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chinedozi, I.D., Wessler, B. (2020). Evolution of Modern Cardiovascular Quality Metrics. In: Salem, D. (eds) Quality Measures. Springer, Cham. https://doi.org/10.1007/978-3-030-37145-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-37145-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37144-9
Online ISBN: 978-3-030-37145-6
eBook Packages: MedicineMedicine (R0)